Shatavari (Expanded) for Fertility Support

Research suggests that Shatavari (Asparagus racemosus) may support female fertility and reproductive health through multiple mechanisms, with studies pointing to potential benefits for PCOS-related symptoms, hormonal balance, ovarian function, and perimenopausal markers such as AMH levels. The evidence base includes two recent randomized controlled trials specifically examining PCOS and perimenopausal populations, alongside several narrative and literature reviews, with the overall direction of findings being supportive — one RCT found reductions in follicular count and psychological stress in PCOS women, while another found favorable shifts in FSH, LH, and AMH in perimenopausal women, and a separate RCT reported reductions in ovarian cyst size and follicle number. Proposed mechanisms include the activity of steroidal saponins such as Shatavarin IV, which molecular docking studies suggest may interact with key reproductive hormone receptors including FSH, LH, estrogen, and progesterone receptors, and antioxidant properties that may help mitigate stress-induced impairments to ovarian function. However, the overall body of evidence remains early-stage, with small sample sizes, short study durations, and limited clinical trials, meaning the research community broadly agrees that more rigorous, large-scale studies are needed before firm conclusions about efficacy and safety can be drawn.